CELLECT Laboratories Revenue

About CELLECT Laboratories

At CELLECT, we are on a mission to revolutionize women’s healthcare. Every year, over a billion women worldwide are at risk of HPV and cervical cancer, yet many avoid or delay screenings due to discomfort, inconvenience, and fear. The current method of screening, the pap smear, is outdated and often inaccessible for many women, especially in underserved communities. That’s why CELLECT is transforming reproductive health screenings. Our innovative, non-invasive technology uses a simple tampon or pad to collect menstrual blood, allowing for high-accuracy testing for HPV and cervical cancer—no speculum required, no invasive procedures. Our proprietary nanomaterial extracts and stabilizes DNA, making it compatible with existing gold-standard diagnostic tests while streamlining lab processing. CELLECT is not only easier and more comfortable for women, but it’s also cost-effective and accurate. We’re focused on bringing this solution to women everywhere, starting with provincial screening programs in Canada and expanding globally. Our vision is to make proactive health screenings more accessible, affordable, and dignified for all women. Join the movement to #ScrapThePap and learn more about how we’re changing the face of women’s health at www.cellectlaboratories.com

View contact profiles from CELLECT Laboratories